Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Panamá
Abstract
Authors
Z. Desanvicente-Celis C.A. Obando E. Rodriguez L. Gonzalez D. Muschett